EUVIMEDEUVIMED entdecken
Crossref

Baicalin Alleviates Chronic Pancreatitis Fibrosis and Islet Dysfunction via Targeting IFNAR ‐Mediated JAK / STAT Signaling and Immune Modulation

Hehe Dou, Rui Tao, Kan Yue, Feng Cheng, Zhipeng Xu, Zhenjie Wang, Chuanming Zheng iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501649r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Hehe Dou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Surgery Department, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China. Hauptthemen laut MEDLINE: Flavonoids, Pancreatitis, Chronic, Signal Transduction, STAT Transcription Factors. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Key Natural Science Research Project of Anhui Provincial Department of Education, General Program of Natural Science Foundation of Bengbu Medical University, Scientific Research Project of Bengbu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pancreatitis (CP) is characterized by progressive fibrosis and islet dysfunction, yet effective therapeutic strategies remain limited. This study elucidates the mechanism by which baicalin ameliorates CP progression through modulation of the interferon‐α/β receptor (IFNAR)/janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway. In a caerulein‐induced CP rat model, baicalin treatment (100 mg/kg/day, 6 weeks) markedly reduced pancreatic injury, collagen deposition, and α‐smooth muscle actin (α‐SMA) expression, alongside decreased serum levels of IL‐6, TNF‐α, TGF‐β, amylase, and lipase. Flow cytometry revealed that baicalin suppressed pancreatic infiltration of CD8 + T cells, macrophages, and NK cells while elevating regulatory T (Treg) cell proportions. Transcriptomic analysis identified JAK/STAT signaling as a key pathway inhibited by baicalin, with molecular docking confirming its direct binding to IFNAR. In vitro, baicalin (10 μM) attenuated TGF‐β1‐activated pancreatic stellate cell (PSC) activation, evidenced by reduced lipid droplet loss and α‐SMA/COL1A1 expression. Overexpression of IFNAR reversed baicalin's anti‐fibrotic effects, whereas co‐treatment with the JAK inhibitor ruxolitinib partially restored its efficacy. In vivo, IFNAR overexpression diminished baicalin's therapeutic benefits, but ruxolitinib co‐administration mitigated pancreatic damage. These findings demonstrate that baicalin alleviates CP fibrosis and islet dysfunction by targeting IFNAR to suppress JAK/STAT signaling, modulating immune cell dynamics, and inhibiting PSC activation. This study highlights IFNAR as a novel therapeutic target and positions baicalin as a promising candidate for CP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsPancreatitis, ChronicSignal TransductionSTAT Transcription FactorsJanus KinasesIslets of LangerhansAnimalsRatsMaleFibrosisRats, Sprague-DawleyPancreatic Stellate Cells

Stichwörter der Autor:innen

BaicalinIFNARJAK/STAT signalingchronic pancreatitispancreatic fibrosis

Substanzen

baicalinFlavonoidsSTAT Transcription FactorsJanus Kinases

Autor:innen und Institutionen

  • Emergency Surgery Department, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Department of Graduate Studies, Bengbu Medical College, Bengbu, China.
  • Department of Graduate Studies, Guangxi Medical University, Nanning, China.

ORCID-Profile: Chuanming Zheng

Förderung

  • Key Natural Science Research Project of Anhui Provincial Department of Education
  • General Program of Natural Science Foundation of Bengbu Medical University
  • Scientific Research Project of Bengbu Medical College

Zitieren

APA

Dou, H., Tao, R., Yue, K., Cheng, F., Xu, Z., Wang, Z., & Zheng, C. (2025). Baicalin Alleviates Chronic Pancreatitis Fibrosis and Islet Dysfunction via Targeting IFNAR ‐Mediated JAK / STAT Signaling and Immune Modulation. The FASEB Journal. https://doi.org/10.1096/fj.202501649r

Vancouver

Dou H, Tao R, Yue K, Cheng F, Xu Z, Wang Z, et al. Baicalin Alleviates Chronic Pancreatitis Fibrosis and Islet Dysfunction via Targeting IFNAR ‐Mediated JAK / STAT Signaling and Immune Modulation. The FASEB Journal. 2025. doi:10.1096/fj.202501649r

BibTeX
@article{Dou2025,
  author = {Dou, Hehe and Tao, Rui and Yue, Kan and Cheng, Feng and Xu, Zhipeng and Wang, Zhenjie and Zheng, Chuanming},
  title = {Baicalin Alleviates Chronic Pancreatitis Fibrosis and Islet Dysfunction via Targeting IFNAR ‐Mediated JAK / STAT Signaling and Immune Modulation},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501649r}
}
Kostenlos starten →